CELLULAR PATHWAY FOR REJECTION OF CLASS I MHC DISPARATE SKIN AND TUMOR ALLOGRAFTS

被引：0
|
作者：
SMITH, DM [1 ]
STUART, FP [1 ]
FITCH, FW [1 ]
机构：
[1] UNIV CHICAGO,CHICAGO,IL 60637
来源：
FEDERATION PROCEEDINGS | 1987年 / 46卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：756 / 756
页数：1
相关论文
共 50 条
  • [1] CELLULAR PATHWAYS FOR REJECTION OF CLASS-I-MHC DISPARATE SKIN AND TUMOR ALLOGRAFTS
    SMITH, DM
    STUART, FP
    WEMHOFF, GA
    QUINTANS, J
    FITCH, FW
    TRANSPLANTATION, 1988, 45 (01) : 168 - 175
  • [2] T-CELL SUBSETS AND REJECTION OF MHC CLASS-I DISPARATE ALLOGRAFTS
    MAYER, TG
    WINN, HJ
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 610 - 610
  • [3] Interferon-gamma (IFN gamma) is necessary for acute rejection of MHC class II-disparate skin allografts but is not required for MHC class I rejection.
    Saleem, S
    Konieczny, BT
    Baddoura, FK
    Lakkis, FG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3100 - A3100
  • [4] Antibody-Mediated Rejection of Single Class I MHC-Disparate Cardiac Allografts
    Hattori, Y.
    Bucy, R. P.
    Kubota, Y.
    Baldwin, W. M., III
    Fairchild, R. L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (08) : 2017 - 2028
  • [5] Delayed rejection of MHC class II-disparate skin allografts in mice treated with farnesyltransferase inhibitors
    Gaylo, Alison E.
    Laux, Kathleen S.
    Batzel, Erika J.
    Berg, Morgan E.
    Field, Kenneth A.
    TRANSPLANT IMMUNOLOGY, 2009, 20 (03) : 163 - 170
  • [6] Rejection of Single Class I MHC Disparate Heart Allografts in CCR5-Deficient Recipients
    Hattori, Y.
    Setoguchi, K.
    Fairchild, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 232 - 232
  • [7] IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice
    Le Moine, A
    Surquin, M
    Demoor, FX
    Noël, JC
    Nahori, MA
    Pretolani, M
    Flamand, V
    Braun, MY
    Goldman, M
    Abramowicz, D
    JOURNAL OF IMMUNOLOGY, 1999, 163 (07) : 3778 - 3784
  • [8] Interferon-gamma (IFNg) is necessary for acute rejection of MHC class II-disparate skin grafts but is not required for MHC class I rejection
    Ring, GH
    Saleem, S
    Hassan, AT
    Konieczny, BT
    Baddoura, FK
    Lakkis, FG
    FASEB JOURNAL, 1998, 12 (04) : A267 - A267
  • [9] Chronic antagonism of Mig inhibits cellular infiltration and promotes survival of class II MHC disparate skin allografts.
    Kobayashi, H
    Novick, AC
    Toma, H
    Fairchild, RL
    TRANSPLANTATION, 2002, 74 (03) : 387 - 395
  • [10] MECHANISM OF REJECTION OF MHC CLASS-I-DISPARATE MURINE SKIN-GRAFTS - HISTOLOGICAL AND IMMUNOHISTOCHEMICAL STUDIES OF THE REJECTION PHENOMENON
    KOBAYASHI, E
    KAWAI, K
    ITO, M
    MATSUMOTO, Y
    FUJIWARA, M
    TRANSPLANTATION PROCEEDINGS, 1990, 22 (05) : 2352 - 2357
12345